Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1996
Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and manS G Jezequel, S Uden, P WastallFree Radical Biology & Medicine|January 1, 1990
Heightened free radical activity in pancreatitisP M Guyan, S Uden, J M BraganzaAdvances in Experimental Medicine and Biology|January 1, 1990
Rationale for antioxidant therapy in pancreatitis and cystic fibrosisS Uden, D Bilton, P M Guyan, et al.British Journal of Clinical Pharmacology|December 1, 1987
Theophylline and antipyrine disposition in smoking and non-smoking epileptic subjectsD W Acheson, S Uden, J M Braganza, et al.Alimentary Pharmacology & Therapeutics|August 1, 1990
Antioxidant therapy for recurrent pancreatitis: placebo-controlled trialS Uden, D Bilton, L Nathan, et al.Alimentary Pharmacology & Therapeutics|April 1, 1992
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trialS Uden, D Schofield, P F Miller, et al.American Journal of Respiratory and Critical Care Medicine|July 1, 1994
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humansB J O'Connor, S Uden, T J Carty, et al.European Journal of Clinical Nutrition|July 1, 1988
Antioxidants, enzyme induction, and chronic pancreatitis: a reappraisal following studies in patients on anticonvulsantsS Uden, D W Acheson, J Reeves, et al.The American Review of Respiratory Disease|January 1, 1993
Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergenL M Kuitert, K P Hui, S Uthayarkumar, et al.Pageof 1